(DSP5) Lyxor SP500 Daily (-2x) - Ratings and Ratios
Inverse, Leveraged, Daily, Equity, S&P 500, France
Description: DSP5 Lyxor SP500 Daily (-2x)
The Lyxor S&P500 Daily (-2x) Inverse UCITS ETF C USD (PA:DSP5) is an exchange-traded fund that aims to provide inverse exposure to the S&P 500 Index, amplified by a factor of 2. This means that the fund is designed to perform well when the S&P 500 Index declines, and its returns are expected to be twice the opposite of the indexs daily returns.
As a Trading - Leveraged/Inverse Equity ETF, DSP5 is suited for sophisticated investors seeking to hedge against potential downturns in the US stock market or to speculate on declines in the S&P 500 Index. The funds inverse and leveraged nature makes it a high-risk investment, as its value can fluctuate significantly in response to market movements.
Analyzing the provided
Considering the
Using the available data, we can forecast the ETFs potential performance. Given the current bearish trend and the ETFs inverse nature, a continued decline in the S&P 500 Index could lead to an increase in DSP5s value. However, the leveraged aspect of the fund amplifies potential losses if the index were to rise. Based on the SMA20, SMA50, and SMA200, a potential support level for DSP5 is around 5.50-5.60. If the S&P 500 Index continues to decline, DSP5 may see a short-term bounce or stabilization around this level. Conversely, a reversal in the S&P 500 Index could lead to a significant decline in DSP5s value.
To make informed investment decisions, it is essential to closely monitor the S&P 500 Index and adjust expectations accordingly. Investors should also be aware of the potential risks associated with leveraged and inverse ETFs, including the possibility of significant losses if the market moves against the funds strategy.
Additional Sources for DSP5 ETF
DSP5 ETF Overview
Market Cap in USD | 55m |
Category | Trading - Leveraged/Inverse Equity |
TER | 0.60% |
IPO / Inception | 2015-12-14 |
DSP5 ETF Ratings
Growth Rating | -74.1 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -24.1 |
Analysts | - |
Fair Price Momentum | 3.98 EUR |
Fair Price DCF | - |
DSP5 Dividends
Currently no dividends paidDSP5 Growth Ratios
Growth Correlation 3m | -98.1% |
Growth Correlation 12m | -30.4% |
Growth Correlation 5y | -84.1% |
CAGR 5y | -22.87% |
CAGR/Max DD 5y | -0.31 |
Sharpe Ratio 12m | -1.25 |
Alpha | -9.89 |
Beta | -0.892 |
Volatility | 13.62% |
Current Volume | 3.8k |
Average Volume 20d | 32.2k |
Stop Loss | 5 (-3.5%) |
As of July 12, 2025, the stock is trading at EUR 5.18 with a total of 3,844 shares traded.
Over the past week, the price has changed by +0.90%, over one month by -5.97%, over three months by -18.74% and over the past year by -14.36%.
No, based on ValueRay´s Analyses, Lyxor SP500 Daily (-2x) (PA:DSP5) is currently (July 2025) a stock to sell. It has a ValueRay Growth Rating of -74.05 and therefor a clear technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DSP5 is around 3.98 EUR . This means that DSP5 is currently overvalued and has a potential downside of -23.17%.
Lyxor SP500 Daily (-2x) has no consensus analysts rating.
According to our own proprietary Forecast Model, DSP5 Lyxor SP500 Daily (-2x) will be worth about 4.3 in July 2026. The stock is currently trading at 5.18. This means that the stock has a potential downside of -16.99%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 4.3 | -17% |